Sports participation for athletes with implantable cardioverter-defibrillators should be an individualized risk-benefit decision.
Yale University School of Medicine, Department of Medicine, New Haven, Connecticut, USA. rachel.lampert@yale.edu
Rachel
R
Lampert
David
D
Cannom
D053840:Brugada Syndrome / Q000628:therapy; D002312:Cardiomyopathy, Hypertrophic / Q000628:therapy*; D016757:Death, Sudden, Cardiac / Q000517:prevention & control; D003657:Decision Making; D017147:Defibrillators, Implantable; D006801:Humans; D008133:Long QT Syndrome / Q000628:therapy*; D009043:Motor Activity; D018570:Risk Assessment; D013177:Sports